CO6382136A2 - GLUCAGON ANALOGS - Google Patents
GLUCAGON ANALOGSInfo
- Publication number
- CO6382136A2 CO6382136A2 CO11074017A CO11074017A CO6382136A2 CO 6382136 A2 CO6382136 A2 CO 6382136A2 CO 11074017 A CO11074017 A CO 11074017A CO 11074017 A CO11074017 A CO 11074017A CO 6382136 A2 CO6382136 A2 CO 6382136A2
- Authority
- CO
- Colombia
- Prior art keywords
- methods
- glucagon analogs
- peptides
- glucagon
- glp
- Prior art date
Links
Abstract
La invención proporciona materiales y procedimientos para promover la pérdida de peso o prevenir el aumento de peso y en el tratamiento de diabetes, síndrome metabólico y trastornos asociados. En particular, la invención proporciona nuevos péptidos análogos de glucagón eficaces en tales procedimientos. Los péptidos pueden mediar su efecto teniendo selectividad aumentada para el receptor de GLP-1 en comparación con el glucagón humano.The invention provides materials and methods for promoting weight loss or preventing weight gain and in the treatment of diabetes, metabolic syndrome and associated disorders. In particular, the invention provides novel glucagon analog peptides effective in such methods. Peptides can mediate their effect by having increased selectivity for the GLP-1 receptor compared to human glucagon.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO11074017A CO6382136A2 (en) | 2011-06-14 | 2011-06-14 | GLUCAGON ANALOGS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO11074017A CO6382136A2 (en) | 2011-06-14 | 2011-06-14 | GLUCAGON ANALOGS |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6382136A2 true CO6382136A2 (en) | 2012-02-15 |
Family
ID=45813937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11074017A CO6382136A2 (en) | 2011-06-14 | 2011-06-14 | GLUCAGON ANALOGS |
Country Status (1)
Country | Link |
---|---|
CO (1) | CO6382136A2 (en) |
-
2011
- 2011-06-14 CO CO11074017A patent/CO6382136A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP12011593A (en) | GLUCAGON ANALOGS ACCILATED | |
UY35030A (en) | GLUCAGON ANALOGS | |
UY33462A (en) | GLUCAGON ANALOGS | |
ECSP12012357A (en) | GLUCAGON ANALOGS | |
PH12016500675A1 (en) | Acylated glucagon analogues | |
MX368435B (en) | Glucagon analogues. | |
CL2014003421A1 (en) | Glucagon analogs exhibiting agonist activity at the glusose-dependent insulinotropic peptide receptor (gip): pharmaceutical composition; and method to reduce weight gain or induce weight loss, particularly for the treatment of obesity. | |
MX2017012864A (en) | Acylated glucagon analogue. | |
MX2011006315A (en) | Glucagon analogues. | |
TN2011000295A1 (en) | Glucagon analogues | |
MX2011006320A (en) | Glucagon analogues. | |
MX2011006314A (en) | Glucagon analogues. | |
UY34859A (en) | Peptide analogs of exendin 4. | |
EA201490982A1 (en) | ANALOGUE GLUACAGONA | |
CO6382136A2 (en) | GLUCAGON ANALOGS | |
ECSP15009978A (en) | GLUCAGON ANALOGUES | |
TN2011000667A1 (en) | Acylated glucagon analogues |